MedPath

Senju Pharmaceutical Science&Technology(Beijing)Co.,Ltd

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease

Phase 3
Recruiting
Conditions
Dry Eye
Interventions
Drug: Placebo
First Posted Date
2024-12-04
Last Posted Date
2025-04-20
Lead Sponsor
Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd.
Target Recruit Count
400
Registration Number
NCT06717152
Locations
🇨🇳

Beijing Hospital, Beijing, Beijing, China

🇨🇳

Beijing Tongren Hospital, Beijing, Beijing, China

🇨🇳

Peking Union Medical College Hospital, Beijing, Beijing, China

and more 33 locations
© Copyright 2025. All Rights Reserved by MedPath